EH301

DIETARY_SUPPLEMENT2 trials

Sponsors

Elysium Health, Biogipuzkoa Health Research Institute

Conditions

Amyotrophic Lateral Sclerosis

Phase 1

Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)

RecruitingNCT07414212

Biogipuzkoa Health Research InstituteAmyotrophic Lateral Sclerosis

Start: 2025-11-25End: 2027-11-25Target: 90Updated: 2026-02-17

Unknown Phase

EH301 for the Treatment of ALS

CompletedNCT03489200

Elysium HealthAmyotrophic Lateral Sclerosis

Start: 2017-01-31End: 2017-06-30Updated: 2018-05-18

Related Papers

Effect of the Mediterranean diet supplemented with nicotinamide riboside and pterostilbene and/or coconut oil on anthropometric variables in amyotrophic lateral sclerosis. A pilot study

Frontiers in Nutrition2023-09-2216 citations